Mario V Aquino

Learn More
OBJECTIVE To demonstrate that the intraocular pressure (IOP)-reducing effect of latanoprost once daily is at least as good as that of timolol twice daily in patients with chronic angle-closure glaucoma (CACG). DESIGN Randomized, double-masked, multicenter 12-week study. PARTICIPANTS In all, 137 patients with unilateral or bilateral CACG were treated(More)
PURPOSE To determine whether selective laser trabeculoplasty (SLT) can lower intraocular pressure (IOP) in eyes with chronic primary angle closure, elevated IOP, and a patent iridotomy. PATIENTS AND METHODS Patients with chronic angle closure who had underwent iridotomy, had an IOP greater than 21 mm Hg and a gonioscopically visible pigmented trabecular(More)
  • 1